pharmaphorum

AUGUST 21, 2020

New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate hit the headlines this week as the COVID-19 coronavirus pandemic continues. Here we highlight the biggest R&D, market access and digital coronavirus news of the past week.

Vaccines 105

Vaccines 105

pharmaphorum

NOVEMBER 19, 2020

The coronavirus vaccine being developed by Oxford University and AstraZeneca produces a strong immune response in higher risk older patients, a study has found. The post Encouraging data from AZ/Oxford coronavirus shot appeared first on. Booster regimes were given 28 days apart and dosing regimen varied according to age group.

Vaccines 105

Vaccines Immunity Immunization 105

pharmaphorum

SEPTEMBER 14, 2020

AstraZeneca has resumed UK trials for its coronavirus vaccine, after the country’s medicines regulator gave the all-clear following a safety scare. The vaccine is top of the list of 35 potential coronavirus vaccines in clinical development, according to a list maintained by the World Health Organization.

Vaccines 104

Vaccines Immunity Immunization 104

pharmaphorum

AUGUST 14, 2020

Catch up on the latest coronavirus vaccine and digital tech news in our roundup of this week’s biggest stories. Russia has become the first country in the world to approve a coronavirus vaccine , amid scepticism from international experts who have been unable to review or verify clinical data from the jab called ‘Sputnik V’.

Vaccines 98

Vaccines Hospitals 98

pharmaphorum

SEPTEMBER 30, 2020

Regeneron’s antibody cocktail seems to reduce levels of coronavirus and improve symptoms in patients, according to early test results. The post Regeneron’s antibody cocktail active against coronavirus, cuts symptoms appeared first on.

Immunity 135

Immunity Immunization 135

pharmaphorum

FEBRUARY 18, 2021

GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and other respiratory viruses. The first is an expansion of their current functional genomics collaboration to develop potential pan-coronavirus therapeutics to now include other respiratory virus targets.

112

112

pharmaphorum

AUGUST 11, 2020

Russia has become the first country in the world to approve a coronavirus vaccine, amid scepticism from international experts who have been unable to review or verify clinical data from the jab called ‘Sputnik V’ According to press reports the vaccine has been tested on one of President Vladimir Putin’s daughters.

Vaccines 98

Vaccines Immunity Immunization 98

pharmaphorum

MAY 10, 2021

Coronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine rollout scheme, Dr Clive Dix. He told the newspaper that the country is on track to meet its target of giving at least one shot of coronavirus vaccine to all adults by the end of July.

Vaccines 124

Vaccines 124

STAT

MARCH 28, 2024

While an increasingly anxious world watched a new coronavirus spread across the globe in early 2020, veteran immunologist Rafi Ahmed quickly grasped that his field was about to experience something truly extraordinary.

Immunity 363

Immunity Immunization Vaccines 363

pharmaphorum

MARCH 16, 2021

Roche has launched a new test that will help monitor emerging variants of the SARS-CoV-2 coronavirus. The post Roche launches test to monitor emerging coronavirus variants appeared first on. The company’s high-throughput polymerase chain reaction (PCR) test has also been CE Mark approved.

Vaccines 108

Vaccines 108

pharmaphorum

SEPTEMBER 4, 2020

Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine, as AstraZeneca expanded studies of its rival into Japan. The move brings the total number of coronavirus vaccines in development across the world to 34, according to a regularly updated list maintained by the World Health Organization.

Vaccines 106

Vaccines Immunity Immunization 106

pharmaphorum

OCTOBER 14, 2020

There is growing evidence that the coronavirus may be able to re-infect patients, and a new instance of a second infection has been confirmed in the US. . It’s the first such case to emerge with the coronavirus, although sudden hearing loss can follow other viral infections including flu.

Immunity 98

Immunity Immunization Hospitals 98

STAT

MAY 8, 2024

They endure prolonged isolation and sacrifice vital economic, emotional, and societal connections, yearning for a return to normalcy even as the coronavirus remains indifferent to their pleas. Their unique circumstances demand a comprehensive and tailored approach to health care that is both accessible and inclusive. Read the rest…

Chemotherapy 247

Chemotherapy Immunity Immunization 247

STAT

APRIL 18, 2024

Even as evidence grew that coronavirus-laced particles could linger in the air indoors and infect people nearby, and researchers raised the alarm about the risks this posed to health care workers and the general public, the WHO didn’t acknowledge that Covid was airborne until late 2021.

363

363

pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic.

Vaccines 105

Vaccines Packaging 105

Pharma Times

APRIL 6, 2021

Everyone in England, including those without symptoms, will be able to take a free rapid coronavirus test twice a week

65

65

Pharma Times

AUGUST 24, 2020

A 33-year-old man was infected twice with slightly different strains of coronavirus more than four months apart

88

88

STAT

OCTOBER 2, 2023

Overcoming a lack of broader interest in their work and scientific challenges, Katalin Karikó and Drew Weissman made key discoveries about messenger RNA that enabled scientific teams to start developing the tool into therapies, immunizations, and — as the pandemic spread in 2020 — vaccines targeting the SARS-CoV-2 coronavirus.

Immunity 363

Immunity Immunization Vaccines 363

STAT

JANUARY 25, 2024

LONDON — Two research centers that have been at the forefront of following the evolution of the SARS-CoV-2 coronavirus — one in the U.K. and one in South Africa — have teamed up on a partnership that they say will expand their efforts to track emerging disease threats around the world. The collaboration between the U.K.’s

333

333

STAT

JULY 21, 2023

WASHINGTON – The White House on Friday launched its pandemic preparedness office, half a year after Congress instructed the administration to set up a new arm in the wake of the coronavirus pandemic. The creation of a pandemic preparedness office was one of the last major bipartisan pushes for Sen. Richard Burr (R-N.C.) He and Sen.

Packaging 246

Packaging 246

pharmaphorum

FEBRUARY 8, 2021

The post China approves Sinovac’s coronavirus vaccine appeared first on. The main target for the scheme will be developing countries as many high GDP nations have already snapped up hundreds of millions of doses each with their national vaccination schemes. Feature image courtesy of Rocky Mountain Laboratories/NIH.

Vaccines 90

Vaccines Immunity Immunization 90

STAT

FEBRUARY 28, 2024

A new study published Wednesday in the New England Journal of Medicine, which looks at how much cognition is impaired in the months after a coronavirus infection, shows that Covid-19’s impact can be measured in the equivalent of IQ points.

Hospitals 363

Hospitals 363

pharmaphorum

DECEMBER 10, 2020

The US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should be avoided by people who are prone to serious allergic reactions. The post Coronavirus vaccine may have allergy warning in US, says expert appeared first on.

Vaccines 103

Vaccines Documentation 103

STAT

MAY 10, 2023

On the eve of the expiration date for the federally declared coronavirus public health emergency , White House Covid-19 Response Coordinator Ashish Jha warned that the pandemic is far from over. “I don’t see this as an end to the pandemic or fighting Covid,” Jha said at a STAT event in Boston on Wednesday.

326

326

pharmaphorum

AUGUST 13, 2020

million people – had been infected with coronavirus by the end of June according to an estimate based on antibody tests. Key workers in care homes and health care were among those most likely to have already been infected with the coronavirus. people infected with coronavirus in England – study appeared first on.

90

90

BioPharma Dive

MAY 8, 2024

The move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but struggled to sell it amid competition and the emergence of rare but serious side effects.

Vaccines 106

Vaccines 106

STAT

JUNE 15, 2023

Today’s vaccines still contain the original coronavirus strain, the one that started the pandemic — even though that was long ago supplanted by mutated versions as the virus rapidly evolves. The Covid-19 vaccines are on track for a big recipe change this fall. Read the rest…

Vaccines 243

Vaccines 243

NY Times

JUNE 10, 2021

President Biden announced on Thursday that the United States would donate doses of the Pfizer-BioNTech vaccine to 100 countries over the next year in an effort to address the global coronavirus vaccine shortage.

Vaccines 53

Vaccines Immunity Immunization 53

STAT

JANUARY 10, 2023

Researchers hope the initiative will enable them to better monitor viruses in the U.K. as they change, alert them to any worrisome mutations, and get tipped to the emergence of new viruses.

228

228

STAT

AUGUST 31, 2022

WASHINGTON — Federal health officials are starting to push new, variant-targeting vaccines that they say will curb a winter coronavirus wave and protect America’s most medically vulnerable people. The question is whether Americans feel any urgency to get them. Read the rest…

Vaccines 241

Vaccines Hospitals 241

Pharma Times

JANUARY 10, 2024

The partnership will advance VTP-500 from early development to phase 2 clinical trials

Vaccines 109

Vaccines 109

STAT

SEPTEMBER 6, 2022

Because Pfizer and Moderna hold the patents for the current vaccines, researchers would likely have to get the companies’ permission to use them for research into products like nasal or pan-coronavirus vaccines. Right now, Pfizer isn’t sharing its vaccines for research purposes, a spokesperson confirmed to STAT.

Vaccines 364

Vaccines 364

NY Times

DECEMBER 10, 2020

The system that built a coronavirus vaccine in record time relies on robust intellectual property protections.

Vaccines 56

Vaccines Immunity Immunization 56

NY Times

DECEMBER 15, 2020

La revisión positiva probablemente asegure que la Administración de Alimentos y Medicamentos (FDA, por su sigla en inglés) concederá esta semana la autorización de emergencia para una segunda vacuna contra el coronavirus para millones de estadounidenses.

Immunity 58

Immunity Immunization Vaccines 58

Pharmacy Times

DECEMBER 28, 2023

From newsworthy moments to groundbreaking research, these were the most-read coronavirus-related articles on Pharmacy Times in 2023.

26

26

pharmaphorum

AUGUST 21, 2020

Doctors have called for rules to be tightened on coronavirus antibody tests in the UK amid fears that false readings could put the public at risk. It’s not even known for sure that having antibodies against the SARS-CoV-2 coronavirus confers immunity. Feature image courtesy of Rocky Mountain Laboratories/NIH.

Documentation 76

Documentation Immunity Immunization 76

pharmaphorum

JANUARY 20, 2021

UK biotech ConserV Bioscience has joined with California’s Lawrence Livermore National Laboratory to develop broad-spectrum coronavirus vaccines as concerns mount over potentially more infectious strains emerging in the UK, South Africa and Brazil. Feature image courtesy of Rocky Mountain Laboratories/NIH.

Vaccines 52

Vaccines Immunity Immunization 52